| UniProt ID | APTX_HUMAN | |
|---|---|---|
| UniProt AC | Q7Z2E3 | |
| Protein Name | Aprataxin | |
| Gene Name | APTX | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 356 | |
| Subcellular Localization | Nucleus, nucleoplasm . Nucleus, nucleolus . Upon genotoxic stress, colocalizes with XRCC1 at sites of DNA damage (PubMed:15380105). Colocalizes with MDC1 at sites of DNA double-strand breaks (PubMed:20008512). Interaction with NCL is required for nuc | |
| Protein Description | DNA-binding protein involved in single-strand DNA break repair, double-strand DNA break repair and base excision repair. [PubMed: 15380105] | |
| Protein Sequence | MSNVNLSVSDFWRVMMRVCWLVRQDSRHQRIRLPHLEAVVIGRGPETKITDKKCSRQQVQLKAECNKGYVKVKQVGVNPTSIDSVVIGKDQEVKLQPGQVLHMVNELYPYIVEFEEEAKNPGLETHRKRKRSGNSDSIERDAAQEAEAGTGLEPGSNSGQCSVPLKKGKDAPIKKESLGHWSQGLKISMQDPKMQVYKDEQVVVIKDKYPKARYHWLVLPWTSISSLKAVAREHLELLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHVISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 26 | Phosphorylation | CWLVRQDSRHQRIRL HHHHCCCCCCCCCCC | 24.27 | 27067055 | |
| 30 (in isoform 4) | Phosphorylation | - | 15.18 | - | |
| 39 | Ubiquitination | RLPHLEAVVIGRGPE CCCCEEEEEECCCCC | 2.05 | 24816145 | |
| 53 | Ubiquitination | ETKITDKKCSRQQVQ CCCCCCCCCCHHHHH | 40.01 | 24816145 | |
| 62 | Sumoylation | SRQQVQLKAECNKGY CHHHHHHHHHCCCCE | 25.66 | - | |
| 62 | Sumoylation | SRQQVQLKAECNKGY CHHHHHHHHHCCCCE | 25.66 | - | |
| 67 | Phosphorylation | QLKAECNKGYVKVKQ HHHHHCCCCEEEEEE | 64.38 | 33259812 | |
| 75 | Ubiquitination | GYVKVKQVGVNPTSI CEEEEEEECCCCCCC | 8.39 | 29967540 | |
| 84 | O-linked_Glycosylation | VNPTSIDSVVIGKDQ CCCCCCCEEEECCCC | 19.33 | 29351928 | |
| 89 | Ubiquitination | IDSVVIGKDQEVKLQ CCEEEECCCCCEEEC | 45.15 | - | |
| 98 | Ubiquitination | QEVKLQPGQVLHMVN CCEEECCCCHHHHHH | 19.78 | 29967540 | |
| 107 | Ubiquitination | VLHMVNELYPYIVEF HHHHHHHHHHHHHHC | 4.38 | 29967540 | |
| 118 | Ubiquitination | IVEFEEEAKNPGLET HHHCHHHHCCCCCHH | 21.87 | 29967540 | |
| 118 (in isoform 7) | Phosphorylation | - | 21.87 | - | |
| 121 | Phosphorylation | FEEEAKNPGLETHRK CHHHHCCCCCHHHHH | 48.30 | 33259812 | |
| 125 | Phosphorylation | AKNPGLETHRKRKRS HCCCCCHHHHHHHCC | 31.83 | 22817900 | |
| 132 | Phosphorylation | THRKRKRSGNSDSIE HHHHHHCCCCCCCHH | 45.41 | 29255136 | |
| 132 (in isoform 11) | Phosphorylation | - | 45.41 | - | |
| 135 | Phosphorylation | KRKRSGNSDSIERDA HHHCCCCCCCHHHHH | 35.94 | 22167270 | |
| 137 | Phosphorylation | KRSGNSDSIERDAAQ HCCCCCCCHHHHHHH | 26.60 | 22167270 | |
| 138 | Ubiquitination | RSGNSDSIERDAAQE CCCCCCCHHHHHHHH | 6.37 | 33845483 | |
| 150 | Phosphorylation | AQEAEAGTGLEPGSN HHHHHCCCCCCCCCC | 45.71 | 30576142 | |
| 152 | Ubiquitination | EAEAGTGLEPGSNSG HHHCCCCCCCCCCCC | 7.83 | 29967540 | |
| 156 | Phosphorylation | GTGLEPGSNSGQCSV CCCCCCCCCCCCCCC | 38.24 | 29632367 | |
| 158 | Phosphorylation | GLEPGSNSGQCSVPL CCCCCCCCCCCCCEE | 31.75 | 29632367 | |
| 161 | Ubiquitination | PGSNSGQCSVPLKKG CCCCCCCCCCEECCC | 5.16 | 29967540 | |
| 162 | Phosphorylation | GSNSGQCSVPLKKGK CCCCCCCCCEECCCC | 20.91 | 29632367 | |
| 166 | Acetylation | GQCSVPLKKGKDAPI CCCCCEECCCCCCCC | 54.10 | 26051181 | |
| 166 | Ubiquitination | GQCSVPLKKGKDAPI CCCCCEECCCCCCCC | 54.10 | - | |
| 171 | Ubiquitination | PLKKGKDAPIKKESL EECCCCCCCCCHHHH | 15.94 | 29967540 | |
| 172 | Ubiquitination | LKKGKDAPIKKESLG ECCCCCCCCCHHHHC | 49.41 | 29967540 | |
| 175 | Ubiquitination | GKDAPIKKESLGHWS CCCCCCCHHHHCCHH | 53.94 | - | |
| 177 | Phosphorylation | DAPIKKESLGHWSQG CCCCCHHHHCCHHCC | 48.83 | 25159151 | |
| 182 | Phosphorylation | KESLGHWSQGLKISM HHHHCCHHCCCEEEE | 14.54 | 29449344 | |
| 186 | Ubiquitination | GHWSQGLKISMQDPK CCHHCCCEEEECCCC | 39.29 | - | |
| 189 | Ubiquitination | SQGLKISMQDPKMQV HCCCEEEECCCCCCE | 6.28 | 33845483 | |
| 192 | Ubiquitination | LKISMQDPKMQVYKD CEEEECCCCCCEECC | 19.68 | 33845483 | |
| 198 | Sumoylation | DPKMQVYKDEQVVVI CCCCCEECCCEEEEE | 56.80 | - | |
| 198 | Acetylation | DPKMQVYKDEQVVVI CCCCCEECCCEEEEE | 56.80 | 26051181 | |
| 198 | Sumoylation | DPKMQVYKDEQVVVI CCCCCEECCCEEEEE | 56.80 | - | |
| 198 | Ubiquitination | DPKMQVYKDEQVVVI CCCCCEECCCEEEEE | 56.80 | - | |
| 208 | Acetylation | QVVVIKDKYPKARYH EEEEEECCCCCCCEE | 59.45 | 26051181 | |
| 209 | Phosphorylation | VVVIKDKYPKARYHW EEEEECCCCCCCEEE | 21.79 | - | |
| 214 | Phosphorylation | DKYPKARYHWLVLPW CCCCCCCEEEEEEEC | 11.38 | 23898821 | |
| 225 | Ubiquitination | VLPWTSISSLKAVAR EEECCCHHHHHHHHH | 29.41 | 29967540 | |
| 225 | Phosphorylation | VLPWTSISSLKAVAR EEECCCHHHHHHHHH | 29.41 | 24719451 | |
| 239 | Ubiquitination | REHLELLKHMHTVGE HHHHHHHHHHCCCCC | 52.05 | - | |
| 243 | Ubiquitination | ELLKHMHTVGEKVIV HHHHHHCCCCCEEEE | 23.72 | 33845483 | |
| 257 | Acetylation | VDFAGSSKLRFRLGY EECCCCCCEEEEEEC | 45.43 | 25953088 | |
| 328 | Ubiquitination | DGMPELLKLPLRCHE CCCHHHHHCCCCHHH | 61.76 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 125 | T | Phosphorylation | Kinase | PRKCG | P05129 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of APTX_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of APTX_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| XRCC1_HUMAN | XRCC1 | physical | 15555565 | |
| PARP1_HUMAN | PARP1 | physical | 15555565 | |
| P53_HUMAN | TP53 | physical | 15044383 | |
| XRCC1_HUMAN | XRCC1 | physical | 15044383 | |
| PARP1_HUMAN | PARP1 | physical | 15044383 | |
| TRI37_HUMAN | TRIM37 | physical | 16713569 | |
| XRCC4_HUMAN | XRCC4 | physical | 16713569 | |
| CE350_HUMAN | CEP350 | physical | 16713569 | |
| ZEP1_HUMAN | HIVEP1 | physical | 16713569 | |
| CACO1_HUMAN | CALCOCO1 | physical | 16713569 | |
| CNTRB_HUMAN | CNTROB | physical | 16713569 | |
| SYT17_HUMAN | SYT17 | physical | 16713569 | |
| MABP1_HUMAN | MAPKBP1 | physical | 16713569 | |
| MBP_HUMAN | MBP | physical | 16713569 | |
| TSYL2_HUMAN | TSPYL2 | physical | 16713569 | |
| XRCC1_HUMAN | XRCC1 | physical | 16713569 | |
| ZN639_HUMAN | ZNF639 | physical | 16713569 | |
| PICK1_HUMAN | PICK1 | physical | 16713569 | |
| DNLI3_HUMAN | LIG3 | physical | 15367657 | |
| DDX21_HUMAN | DDX21 | physical | 15367657 | |
| XRCC1_HUMAN | XRCC1 | physical | 15367657 | |
| HSP74_HUMAN | HSPA4 | physical | 15367657 | |
| BAD_HUMAN | BAD | physical | 28514442 | |
| KIF3A_HUMAN | KIF3A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 208920 | Ataxia-oculomotor apraxia syndrome (AOA) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...